Technology News and Research

RSS

Videogames can be used for educational and treatment purposes for young people with ASD

According to the Centers for Disease Control and Prevention (CDC), 1 in 88 children in the U.S. has autism spectrum disorder (ASD), a broad group of neurodevelopmental disorders.

7 Sep 2012

GENCODE Consortium uncovers staggering array of genes in human genome

The GENCODE Consortium expects the human genome has twice as many genes than previously thought, many of which might have a role in cellular control and could be important in human disease. This remarkable discovery comes from the GENCODE Consortium, which has done a painstaking and skilled review of available data on gene activity.

7 Sep 2012

Early results of transcatheter valve registry data unveiled

The 1-month follow-up results of the Transcatheter Valve Treatment Sentinel Pilot Registry have provided data on factors associated with transcatheter aortic valve implantation, as well as short-term outcomes, in Europe.

6 Sep 2012

Estech introduces COBRA Fusion ablation system

Estech, a leading provider of minimally invasive cardiac ablation devices, today announced the market release of its COBRA Fusion ablation system.

6 Sep 2012

Harvard experts create biocompatible hydrogel

A team of experts in mechanics, materials science, and tissue engineering at Harvard have created an extremely stretchy and tough gel that may pave the way to replacing damaged cartilage in human joints.

6 Sep 2012

Injecting capsule with heat-generating cells reduces abdominal and belly fat in mice

The injection of a tiny capsule containing heat-generating cells into the abdomens of mice led those animals to burn abdominal fat and initially lose about 20 percent of belly fat after 80 days of treatment.

6 Sep 2012

Tampere University of Technology to construct human 3D neuronal structure

European Commission's Future and Emerging Technologies (FET) scheme has granted 4 M- to an international consortium aiming to construct a functional 3D neuronal structure mimicking the human brain. The project titled "Biomimicking the brain - towards 3D neuronal network dynamics" is planned to last for the period 1.7.2012.12.2014.

6 Sep 2012

Clinical trial to test combination of two drugs in treating fibromyalgia

A chronic pain condition and numerous gastrointestinal disorders may all be caused by a virus. That's a Tuscaloosa-based surgeon's theory likely headed for a clinical trial early next year and one drawing support from a University of Alabama researcher who studies how viruses replicate.

6 Sep 2012

Latest round of health IT regs will be topic of Capitol Hill hearing

The House hearing is planned in order to give lawmakers a chance to review a proposed rulemaking regarding incentives for so-called "meaningful use" of health information technology.

6 Sep 2012

UC Davis plans to open West Coast Metabolomics Center

With a $9.3 million startup grant from the National Institutes of Health, the University of California, Davis, has announced plans to open the West Coast Metabolomics Center, a high-tech consortium of research and service laboratories that will help scientists better understand and develop more effective treatments for complex diseases like diabetes, cancer and atherosclerosis.

6 Sep 2012

Akonni receives NSF's Phase 2 SBIR Grant to develop Lab-on-a-Film microarray

Akonni Biosystems, a life science tools / molecular diagnostics company that develops, manufactures, and plans to market molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $498,780 Phase 2 SBIR Grant from the National Science Foundation (NSF).

6 Sep 2012

SSM Center for Sleep Disorders, NovaSom announce first AccuSom Deliver partnership

NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, announces its first AccuSom Deliver partnership with SSM Center for Sleep Disorders, a service of SSM Health Care - St. Louis, making convenient, efficient Out-of-Center Sleep Testing (OCST) available to patients at seven locations throughout the area beginning October 1, 2012.

6 Sep 2012

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.

6 Sep 2012

Hendricks Regional Health implements Heart IT's WebPAX to help manage cardiac images

Heart IT, the global leader that pioneered the first FDA approved zero-footprint medical imaging workstation, has joined Hendricks Regional Health to announce the implementation of Heart IT's WebPAX platform to help manage and distribute cardiac images.

6 Sep 2012

DuraSite 2 ophthalmic drug delivery system from InSite Vision

InSite Vision Incorporated today introduced DuraSite 2, its next-generation enhanced drug delivery system which provides a broad platform for developing superior ophthalmic therapeutics.

6 Sep 2012

Kinetic Concepts launches Skin IQ 1000 MCM to help prevent and treat stage I-IV pressure ulcers

Kinetic Concepts, Inc. (KCI) announced today the U.S. launch of the Skin IQ 1000 Microclimate Manager (MCM) by its Therapeutic Support Systems (TSS) business.

6 Sep 2012

Complex spine minimally invasive retractor system launched by K2M

K2M, Inc., the largest privately held spinal device company in the world focused on developing innovative solutions for the treatment of complex spinal pathologies and minimally invasive procedures, today announced the launch of the SERENGETI® Complex Spine Minimally Invasive Retractor System at the Scoliosis Research Society (SRS) 47th Annual Meeting in Chicago.

5 Sep 2012

Researchers discover two gene variants that raise risk of pediatric cancer neuroblastoma

Researchers have discovered two gene variants that raise the risk of the pediatric cancer neuroblastoma. Using automated technology to perform genome-wide association studies on DNA from thousands of subjects, the study broadens understanding of how gene changes may make a child susceptible to this early childhood cancer, as well as causing a tumor to progress.

5 Sep 2012

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

5 Sep 2012

NeuroSigma's external Trigeminal Nerve Stimulation system awarded CE Certification

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that it received CE Certification for its external Trigeminal Nerve Stimulation (eTNS) system, called the Monarch, for the adjunctive treatment of epilepsy and major depressive disorder, for adults and children 9 years and older.

5 Sep 2012

Technology News and Research

Videogames can be used for educational and treatment purposes for young people with ASD

GENCODE Consortium uncovers staggering array of genes in human genome

Early results of transcatheter valve registry data unveiled

Estech introduces COBRA Fusion ablation system

Harvard experts create biocompatible hydrogel

Injecting capsule with heat-generating cells reduces abdominal and belly fat in mice

Tampere University of Technology to construct human 3D neuronal structure

Clinical trial to test combination of two drugs in treating fibromyalgia

Latest round of health IT regs will be topic of Capitol Hill hearing

UC Davis plans to open West Coast Metabolomics Center

Akonni receives NSF's Phase 2 SBIR Grant to develop Lab-on-a-Film microarray

SSM Center for Sleep Disorders, NovaSom announce first AccuSom Deliver partnership

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

Hendricks Regional Health implements Heart IT's WebPAX to help manage cardiac images

DuraSite 2 ophthalmic drug delivery system from InSite Vision

Kinetic Concepts launches Skin IQ 1000 MCM to help prevent and treat stage I-IV pressure ulcers

Complex spine minimally invasive retractor system launched by K2M

Researchers discover two gene variants that raise risk of pediatric cancer neuroblastoma

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

NeuroSigma's external Trigeminal Nerve Stimulation system awarded CE Certification

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News